Deverra Therapeutics Inc Sustainability Reports
Deverra Therapeutics, Inc. is a clinical-stage biotechnology company that develops allogeneic, off-the-shelf universal donor cellular immunotherapies to treat cancer and other life-threatening illnesses.
Sector: Manufacturing
Country: United States
Exchange: Unlisted
1 reports from 2023 to 2023
Company Profile
Deverra Therapeutics, Inc. is a clinical-stage biotechnology company that develops allogeneic, off-the-shelf universal donor cellular immunotherapies to treat cancer and other life-threatening illnesses.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
